Table 2.

Neurological disorders following COVID-19 vaccines in Iran

Case no	Type of disorder	Age	Gender	Comorbidity	COVID-19 test/history	Vaccine type	Time of incidence	Ref.
1	Facial Paresis	34	Female	Migraine attacks (under treatment)	Not stated	Sputnik V	1 day after the 1st dose	[31]
2	Encephalopathy	27	male	–	Not stated	ChAdOx1-S	8 days after the 1st dose	[32]
3		56	Female	–	Negative	ChAdOx1-S	2 days after the 1st dose	[20]
4	Transverse myelitis	31	Female	–	Negative	ChAdOx1-S	3 weeks after the 1st dose	[33]
5	Acute vestibular neuritis	51	Male	–	Negative	ChAdOx1-S	11 days after the 1st dose	[34]
6	Bell's palsy	27	Female	–	Negative	Sputnik V	3–5 days after the 1st dose	[35]
7		58	Male	Controlled diabetes mellitus	Not stated	Sputnik V	10 days after the 1st dose	[35]
8	Thalamic hemi-chorea	72	Male	History of laparoscopic cholecystectomy	Negative	ChAdOx1-S	9 days after the 1st dose	[36]
9	Guillain–Barre syndrome	60	Male	Controlled hypertension and hypothyroidism	Negative	BBIBP–CorV	20 days after the booster	[37]
10		46	Male	–	Negative	ChAdOx1-S	3 days after the 2nd dose	[38]
11		36	Male	–	Negative	BBIBP–CorV	5 days after the 1st dose	[38]
12		32	Male	–	Negative	BBIBP–CorV	14 days after the 1st dose	[38]
13		68	female	–	Negative	ChAdOx1-S	4 days post the 2nd	[39]
14	Aseptic meningitis	26	Female	–	Negative	ChAdOx1-S	A few hours the 1st dose	[40]
15	Extensive myelitis	71	Male	Diabetes mellitus, hypertension and Ischemic Heart Disease	Not stated	BBIBP–CorV	5 days after the 1st dose	[41]
16	Acute disseminated encephalomyelitis	37	Male	–	Negative	BBIBP–CorV	few days to 1 month after the 1st dose	[42]